General

Agreement CCSS-SELNET

For about two years, the team there has been working hard on formalizing a special agreement with the government healthcare institution (CCSS) necessary for the full participation of Costa Rica on all the WP involved in the project.   Last Thursday, September 7th, Dr. Randall Alvarez, Medical Manager from CCSS officially signed the International Collaborative

Read More...

Virtual MDT board (28 July 2022)

Dear SELNET members, The last July 28th hold a new MDT, this time was coordinated by from Hospital oncológico de la provincia de Córdoba,  Argentina. We had interesting cases that were reviewed by the 77 attendees of this meeting. Now you have the opportunity to review them in the following link and suggest your comments: MDTB Selnet 28-7

Read More...

SELNET PATHOLOGY WEBINAR (21 July 2022)

Last July 21st, Dr. Judith Bovee presented a excellent and wonderful talk about “Chondrogenic tumors of bone: an update” it was comprehensive review where we were able to enjoy the different points of view. We obtained the record of attendees in these webinars with a total of 171 and a peak of 100 participants connected at the same time.

Read More...

VIII SELNET CONSORTIUM MEETING COSTA RICA

Dear SELNET members: The upcoming VIII SELNET CONSORTIUM MEETING, programmed for the 3rd– 4th of November, 2022 in Costa Rica. During the Consortium Meeting the accomplished goals, deliverables and pending issues of all WPs will be reviewed + Educational meeting. Agenda will be shared in the upcoming weeks.

Read More...

WEBINAR: CHONDROGENIC TUMORS OF BONE: AN UPDATE.

The next educational webinar from the series of educational webinars within the SELNET pathology network, chaired by Prof Paolo dei Tos is programmed for next July, 21st 4:00-5:30 pm CET “ Chondrogenic tumors of bone: an update  ” Dr. Judith Bovee Do not miss the opportunity of joining the meeting and enjoying the different points of view of our

Read More...

CONGRATULATIONS DR. MARTIN-BROTO

We would like to congratulate to Dr Martin-Broto on his presentation at 2022 ASCO Annual Meeting, where he presented the results of PALBOSARC (GEIS 51). Palbociclib showed signs of activity in this Phase II study on advanced STS patients (several histologic subtypes with the exception of WD/DD liposarcoma), selected based on high expression levels of

Read More...

NATIONAL NEOPLASTIC DISEASE INSITUTE (INEM) IN LIMA HOSTED THE BIANNUAL SELNET CONSORTIUM ON APRIL 28-29TH

NATIONAL NEOPLASTIC DISEASE INSITUTE (INEM) IN LIMA HOSTED THE BIANNUAL SELNET CONSORTIUM ON APRIL 28-29TH The National Neoplastic Disease Institute (INEM) from Lima (Peru) hosted the 7th SELNET consortium last April 28 & 29th. Inaugurated by the General Manager of INEM Dr. Eduardo Payet Meza and the principal investigator of SELNET in Peru, Dr. Victor

Read More...

SELNET PATHOLOGY NETWORK EDUCATIONAL: WEBINAR 15 SEPTEMBER 16:00- 17:30

The next educational webinar from the series of educational webinars within the SELNET pathology network, chaired by Prof Paolo dei Tos is programmed for next 15 September 16:00-17:30 CET “ WHEN DIAGNOSIS DICTATE THERAPY: THE IMPORTANCE OF MULTIDISCIPLINARY APPROACH”  – The standpoint of clinicians for local therapies (Dr Gronchi) – The standpoint of clinicians for

Read More...